Teamwork Financial Advisors LLC Sells 1,239 Shares of Axon Enterprise, Inc $AXON

Teamwork Financial Advisors LLC reduced its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 18.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 5,418 shares of the biotechnology company’s stock after selling 1,239 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in Axon Enterprise were worth $4,486,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Whitaker Myers Wealth Managers LTD. boosted its position in shares of Axon Enterprise by 76.5% during the 2nd quarter. Whitaker Myers Wealth Managers LTD. now owns 1,837 shares of the biotechnology company’s stock valued at $1,521,000 after acquiring an additional 796 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of Axon Enterprise by 19.3% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 3,873 shares of the biotechnology company’s stock valued at $3,206,000 after acquiring an additional 627 shares during the last quarter. TrueWealth Advisors LLC boosted its position in shares of Axon Enterprise by 1.8% during the 2nd quarter. TrueWealth Advisors LLC now owns 1,110 shares of the biotechnology company’s stock valued at $919,000 after acquiring an additional 20 shares during the last quarter. City Center Advisors LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at approximately $426,000. Finally, Capital Market Strategies LLC boosted its position in shares of Axon Enterprise by 2.3% during the 2nd quarter. Capital Market Strategies LLC now owns 2,823 shares of the biotechnology company’s stock valued at $2,337,000 after acquiring an additional 63 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 7,891 shares of Axon Enterprise stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the sale, the insider directly owned 144,538 shares in the company, valued at approximately $108,417,953.80. This trade represents a 5.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Hadi Partovi bought 1,358 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The shares were acquired at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the completion of the transaction, the director owned 237,938 shares of the company’s stock, valued at approximately $176,074,120. The trade was a 0.57% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 44,790 shares of company stock valued at $34,304,947. 4.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on AXON shares. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Needham & Company LLC set a $870.00 target price on Axon Enterprise and gave the company a “buy” rating in a research report on Tuesday, August 5th. JMP Securities increased their target price on Axon Enterprise from $725.00 to $825.00 and gave the company a “market outperform” rating in a research report on Tuesday, July 22nd. Northland Securities set a $800.00 price target on Axon Enterprise in a research report on Tuesday, August 5th. Finally, JPMorgan Chase & Co. raised their price target on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $837.69.

Axon Enterprise Stock Up 0.7%

Shares of AXON opened at $756.13 on Friday. The company has a market cap of $59.36 billion, a PE ratio of 186.70, a P/E/G ratio of 27.57 and a beta of 1.40. The business has a fifty day moving average of $761.10 and a 200 day moving average of $687.25. Axon Enterprise, Inc has a 52-week low of $375.71 and a 52-week high of $885.91. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s revenue was up 32.6% on a year-over-year basis. During the same period last year, the company earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.